{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:40:01Z","timestamp":1756309201229,"version":"3.44.0"},"reference-count":26,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,12,3]]},"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>A female patient presented with stable chronic thrombocytopaenia with large platelets, sensorineuronal deafness and renal impairment. Her treatment was refractory to intravenous immunoglobulins (IVIG) and steroids for a putative diagnosis of immune thrombocytopaenic purpura (ITP). She underwent genetic testing which revealed a MYH9 mutation in-keeping with a diagnosis of Epstein Syndrome. Subsequently to this she developed globally constricted fields on Goldmann visual field testing. MRI pituitary was unremarkable but she was diagnosed with a pituitary microprolactinoma secondary to raised prolactin in the blood responsive to carbegoline therapy. She subsequently developed retinal haemorrhages and recurrent vitreous haemorrhages due to neovascularisation. Fluorescein angiography revealed the extent of the neovascularisation and microvascular ischaemia. She underwent pan-retinal photocoagulation (PRP) to treat the ischaemic stimulus which resulted in regression of the new vessels and cessation of vitreous haemorrhages. There are no previous reported cases of microvascular retinal disease in the literature in the context of Epstein Syndrome, and this is the first report of successful treatment with PRP.<\/jats:p>","DOI":"10.1136\/bcr-2019-231710","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T04:14:23Z","timestamp":1577679263000},"page":"e231710","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["The use of pan-retinal photocoagulation to treat recurrent vitreous haemorrhage with neovascularisation in the context of Epstein syndrome: an MYH9-related disorder"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-7487","authenticated-orcid":false,"given":"Francis William Barwise","family":"Sanders","sequence":"first","affiliation":[{"name":"Eye Treatment Centre, West Suffolk Hospitals NHS Trust, Bury St Edmunds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Thompson","sequence":"additional","affiliation":[{"name":"Eye Treatment Centre, West Suffolk Hospitals NHS Trust, Bury St Edmunds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Roberts","sequence":"additional","affiliation":[{"name":"Eye Treatment Centre, West Suffolk Hospitals NHS Trust, Bury St Edmunds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Gupta","sequence":"additional","affiliation":[{"name":"Eye Treatment Centre, West Suffolk Hospitals NHS Trust, Bury St Edmunds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,12,29]]},"reference":[{"key":"2025082708095264000_12.12.e231710.1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MPH.0b013e318257a64b","article-title":"MYH9-related disorders: report on a patient of Greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation","volume":"34","author":"Economou","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"2025082708095264000_12.12.e231710.2","unstructured":"Savoia A , Pecci A . MYH9-Related Disorders. In: Adam MP , Ardinger HH , Pagon RA , eds. GeneReviews\u00ae [Internet]. Seattle, WA: University of Washington, 1993."},{"key":"2025082708095264000_12.12.e231710.3","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22476"},{"key":"2025082708095264000_12.12.e231710.4","first-page":"103","article-title":"Fechtner syndrome, a nonmuscle myosin heavy chain 9 gene mutation related disease: a case report and literature review]","volume":"32","author":"Hu","year":"2011","journal-title":"Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi"},{"key":"2025082708095264000_12.12.e231710.5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nefro.2018.08.008","article-title":"Myh9 associated nephropathy","volume":"39","author":"Furlano","year":"2019","journal-title":"Nefrolog\u00eda"},{"key":"2025082708095264000_12.12.e231710.6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000320335","article-title":"MYH-9 related platelet disorders: strategies for management and diagnosis","volume":"37","author":"Althaus","year":"2010","journal-title":"Transfus Med Hemother"},{"key":"2025082708095264000_12.12.e231710.7","doi-asserted-by":"publisher","DOI":"10.1086\/324267"},{"key":"2025082708095264000_12.12.e231710.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08716.x"},{"key":"2025082708095264000_12.12.e231710.9","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-02-698035","article-title":"Delayed diagnosis of MYH-9\u2013related disorder and the role of light microscopy in congenital macrothrombocytopenias","volume":"127","author":"Perez Botero","year":"2016","journal-title":"Blood"},{"key":"2025082708095264000_12.12.e231710.10","article-title":"Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 years","volume":"13","author":"Cherif","year":"2018","journal-title":"Lakartidningen"},{"key":"2025082708095264000_12.12.e231710.11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.14639\/0392-100X-702","article-title":"Severe to profound deafness may be associated with MYH9-related disease: report of 4 patients","volume":"36","author":"Canzi","year":"2016","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2025082708095264000_12.12.e231710.12","doi-asserted-by":"publisher","DOI":"10.1177\/1076029607302444"},{"key":"2025082708095264000_12.12.e231710.13","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sft094"},{"key":"2025082708095264000_12.12.e231710.14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(72)90017-4"},{"key":"2025082708095264000_12.12.e231710.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412013312203"},{"key":"2025082708095264000_12.12.e231710.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2017.11.001"},{"key":"2025082708095264000_12.12.e231710.17","doi-asserted-by":"crossref","unstructured":"Duh EJ , Sun JK , Stitt AW . Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight 2017;2.doi:10.1172\/jci.insight.93751","DOI":"10.1172\/jci.insight.93751"},{"key":"2025082708095264000_12.12.e231710.18","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2147\/OPTH.S128506","article-title":"Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives","volume":"11","author":"Bajgai","year":"2017","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"2025082708095264000_12.12.e231710.19","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2298\/VSP150605136R","article-title":"Severe vaso-occlusive retinopathy associated with systemic lupus erythematosus","volume":"73","author":"Radosavljevi\u0107","year":"2016","journal-title":"VSP"},{"key":"2025082708095264000_12.12.e231710.20","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/ICB.0000000000000398","article-title":"Severe bilateral retinal vascular occlusion as first presentation of systemic lupus erythematosus and antiphospholipid syndrome","volume":"11","author":"Storey","year":"2017","journal-title":"Retin Cases Brief Rep"},{"key":"2025082708095264000_12.12.e231710.21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/08820538.2015.1122068","article-title":"Retinal neovascularisation in Susac syndrome: a rare complication","volume":"32","author":"Kumar","year":"2017","journal-title":"Semin Ophthalmol"},{"key":"2025082708095264000_12.12.e231710.22","first-page":"76","article-title":"Neovascular glaucoma following Nd:YAG laser capsulotomy in a patient with diabetes and syphilitic uveitis","volume":"28","author":"Lin","year":"2016","journal-title":"Ci Ji Yi Xue Za Zhi"},{"key":"2025082708095264000_12.12.e231710.23","doi-asserted-by":"crossref","unstructured":"Rodrigues GB , Abe RY , Zangalli C , et al . Neovascular glaucoma: a review. Int J Retin Vitr 2016;2.doi:10.1186\/s40942-016-0051-x","DOI":"10.1186\/s40942-016-0051-x"},{"key":"2025082708095264000_12.12.e231710.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.11.014"},{"key":"2025082708095264000_12.12.e231710.25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2215\/CJN.10581014","article-title":"Ocular features in Alport syndrome: pathogenesis and clinical significance","volume":"10","author":"Savige","year":"2015","journal-title":"CJASN"},{"key":"2025082708095264000_12.12.e231710.26","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.63.741.573"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-231710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:10:01Z","timestamp":1756307401000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-231710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,29]]},"published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1136\/bcr-2019-231710"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-231710","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}